Viewing data from:

PRAZOSIN HYDROCHLORIDE

ANDA

PRAZOSIN HYDROCHLORIDE | A216727 | MSN LABORATORIES PRIVATE LTD

3 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: MINIPRESS(TE code: AB)

API Supply Chain7 active DMFs10 inactive

7 active API suppliers hold Drug Master Files for this ingredient.

SA AJINOMOTO OMNICHEM NVPRAZOSIN HYDROCHLORIDE

DMF 71611987

BIOINDUSTRIA LABORATORIO ITALIANO MEDICINALI SPAPRAZOSIN HYDROCHLORIDE BULK SUBSTANCE

DMF 153212001

NOVITIUM PHARMA LLCPRAZOSIN HYDROCHLORIDE USP

DMF 316282017

MSN ORGANICS PRIVATE LTDPRAZOSIN HYDROCHLORIDE USP (POLYHYDRATE)

DMF 330142018

GRANULES INDIA LTDPRAZOSIN HYDROCHLORIDE USP

DMF 352102020

AURORE LIFE SCIENCES PRIVATE LTDPRAZOSIN HYDROCHLORIDE USP

DMF 354862020

SYNTHOKEM LABS PRIVATE LTDPRAZOSIN HYDROCHLORIDE

DMF 392202024

HEUMANN PCS GMBHInactivePRAZOSIN HYDROCHLORIDE

DMF 61831986

PFC ITALIANA SRL DIV ALFA CHEMICALS ITALIANAInactivePRAZOSIN HYDROCHLORIDE

DMF 63541986

EURAND AMERICA INCInactivePRAZOSIN HYDROCHLORIDE CONTROLLED RELEASE TABLETS

DMF 70321987

SUMITOMO CHEMICAL CO LTDInactivePRAZOSIN HYDROCHLORIDE

DMF 71541987

ABBOTT LABORATORIES CHEMICAL AND AGRICULTURAL PRODUCTS DIVInactivePRAZOSIN HYDROCHLORIDE USP&PRAZOSIN HYDROCHLORIDE,POLYHYDRATE

DMF 72031987

SUMIKA FINE CHEMICALS CO LTDInactivePRAZOSIN HYDROCHLORIDE (POLYHYDRATE)

DMF 77221988

PROSINTEX INDUSTRIE CHIMIQUE ITALIANE SRLInactivePRAZOSIN HYDROCHLORIDE

DMF 77951988

FERMION OYInactivePRAZOSIN HYDROCHLORIDE

DMF 91881991

CHEMICAL PHARMACEUTICAL RESEARCH INSTITUTE NIHFI LTDInactivePRAZOSIN HYDROCHLORIDE

DMF 106781993

STANDARD CHEM AND PHARM CO LTDInactivePRAZOSIN HYDROCHLORIDE

DMF 182342005

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — EQ 1MG BASE

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Sep 17, 2024

No patent or exclusivity listings for this strength.

#002 — EQ 2MG BASE

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Sep 17, 2024

#003 — EQ 5MG BASE

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Sep 17, 2024